A detailed history of Boothbay Fund Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 54,466 shares of RARE stock, worth $2.38 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
54,466
Holding current value
$2.38 Million
% of portfolio
0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.21 - $59.36 $2.19 Million - $3.23 Million
54,466 New
54,466 $3.03 Million
Q3 2023

Nov 14, 2023

BUY
$34.92 - $46.66 $446,871 - $597,108
12,797 Added 51.61%
37,591 $1.34 Million
Q2 2023

Aug 14, 2023

BUY
$37.35 - $52.15 $926,055 - $1.29 Million
24,794 New
24,794 $1.14 Million
Q1 2020

May 15, 2020

SELL
$33.8 - $62.9 $280,168 - $521,378
-8,289 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.08 - $45.83 $299,067 - $379,884
8,289 New
8,289 $354,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.06B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.